arrow
H

Hendrik Van Poppel

ku leuven
H指数:101
被引数:4.2万
浏览量:0

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Prophylactic urethrectomy at the time of radical cystectomy for bladder cancer: does it really have an effect on oncological outcomes?
2025-12-010
PRE
Targeted Prostate Health Checks, a Novel Screening System to Identify Men at Risk of Prostate Cancer: Real-world Evidence from More than 18 000 Prostate-specific Antigen Tests

靶向前列腺健康检查:一种识别前列腺癌高风险男性的新型筛查系统——来自超过18 000次前列腺特异性抗原检测的真实世界证据

2025-11-030
PRE
Evaluation of Ceftaroline Use in Pediatric Patients: A Retrospective Case Series

替加环素在儿科患者中的使用评估:一项回顾性病例系列研究

2025-08-280
OAAI
Urinary bladder cancer needs more attention — recommendations for health care professionals and politicians in the European Union

膀胱癌需要更多关注——面向欧盟卫生保健专业人士和政治家的建议

2025-08-190
PRE
Oncologic Outcomes of Template Versus Radioguided Salvage Lymph Node Dissection for Node-only Recurrent Prostate Cancer on Prostate-specific Membrane Antigen Positron Emission Tomography Scan: Results from a Multi-institutional Collaboration

前列腺特异性膜抗原正电子发射断层扫描中仅淋巴结复发的前列腺癌,模板法与放射引导挽救性淋巴结清扫术的肿瘤学结局:多机构合作研究的结果

2025-08-180
PRE
Prognostic Stratification of pN1 Prostate Cancer After Radical Prostatectomy: A Competing Risk Analysis from a Multi-institutional Cohort

pN1前列腺癌根治性前列腺切除术后预后分层:一项多中心队列的竞争风险分析

2025-08-070
PREAI
MRI capacity assessment for prostate cancer screening in five sites of Europe

欧洲五个地区的MRI能力评估在前列腺癌筛查中的应用

2025-06-160
PRE
Informing prostate cancer screening policy makers in the European Union: lessons from cancer screening governance and policymaking

向欧盟前列腺癌筛查政策制定者提供信息:来自癌症筛查治理和政策制定的教训

2025-06-010
PRE
Risk-stratified Approach to Implementing Population-based Prostate Cancer Screening in Five Pilot Sites in the European Union: A Protocol for the PRAISE-U Project
2024-12-012
OAAI
Prognostic factors in post-prostatectomy salvage radiotherapy setting with and without hormonotherapy: An individual patient data analysis of randomized trials from ICECaP database
2024-12-010
OAAI
Risk of Cancer-related Death for Men with Biopsy Grade Group 1 Prostate Cancer and High-risk Features: A European Multi-institutional Study
2024-08-010
OAAI
Understanding the Barriers to Prostate Cancer Population-Based Early Detection Programs: The PRAISE-U BEST Survey
2024-07-150
OA
Health Policy for Prostate Cancer Early Detection in the European Union and the Impact of Opportunistic Screening: PRAISE-U Consortium

欧盟前列腺癌早期检测的健康政策和机会性筛查的影响: 赞美-U财团

2024-01-117
OAAI
Impact of the Standardization of Penile Cancer Care on the Quality of Care, Outcomes, and Academic-driven Centralization in a Single eUROGEN Referral Center
2024-01-0110
PRE
Early Detection of Prostate Cancer in the European Union: Combining Forces with PRAISE-U
2023-12-0118
PRE
Diabetes, Obesity, and Pathological Upstaging in Renal Cell Carcinoma: Results From a Large Multi-institutional Consortium

肾细胞癌的糖尿病,肥胖和病理升级: 来自大型多机构联盟的结果

2023-11-017
PRE
Morbidity of elective surgery for localized renal masses among elderly patients: A contemporary multicenter study
EJSO
IF2.9
2023-10-013
PRE
How to follow the new EU Council recommendation and improve prostate cancer early detection: the Prostaforum 2022 declaration
2023-07-017
OAAI
ARNEO: A Randomized Phase II Trial of Neoadjuvant Degarelix with or Without Apalutamide Prior to Radical Prostatectomy for High-risk Prostate Cancer

ARNEO: 根治性前列腺切除术前加或不加阿帕鲁胺的新辅助地加瑞克治疗高危前列腺癌的随机II期试验

2023-06-0127
PRE